High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.4M
$3,396,306
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PTCT
S
PTC THERAPEUTICS, INC.
Almstead Neil Gregory
• Officer • CHIEF TECHNICAL OPS OFFICER
10b5-1 SellΔOwn -59.3%
2026-03-05
$252,823
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • CHIEF TECHNICAL OPS OFFICER
10b5-1 SellΔOwn -59.3%
|
2026-03-05 | $252,823 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Golden Lee Scott
• Officer • EVP & CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -11.1%
2026-03-05
$633,800
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EVP & CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -11.1%
|
2026-03-05 | $633,800 | S | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
10b5-1 SellΔOwn -44.2%
|
2026-03-05 | $401,386 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-19
$209,763x4
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-19 | $209,763x4 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Almstead Neil Gregory
• Officer • CHIEF TECHNICAL OPS OFFICER
Sell to Cover
2026-02-18
$216,473x2
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • CHIEF TECHNICAL OPS OFFICER
Sell to Cover
|
2026-02-18 | $216,473x2 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-02-18
$213,698
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-02-18 | $213,698 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Golden Lee Scott
• Officer • EVP & CHIEF MEDICAL OFFICER
Sell to Cover
2026-02-18
$172,290
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EVP & CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-02-18 | $172,290 | S | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
CFO
Sell to Cover
|
2026-02-18 | $207,525 | S | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
CEO
Sell to Cover
|
2026-02-18 | $511,253 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Pauwels Eric
• Officer • CHIEF BUSINESS OFFICER
Sell to Cover
2026-02-18
$209,398
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • CHIEF BUSINESS OFFICER
Sell to Cover
|
2026-02-18 | $209,398 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Utter Christine Marie
• Officer • SVP, CHIEF ACCOUNTING OFFICER
Sell to Cover
2026-02-18
$172,984
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • SVP, CHIEF ACCOUNTING OFFICER
Sell to Cover
|
2026-02-18 | $172,984 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2026-02-17
$72,266
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2026-02-17 | $72,266 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-17
$194,914x2
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-17 | $194,914x2 | S | Form 4 |